Ladenburg Thalmann Financial Services
http://www.ladenburg.comLadenburg Thalmann Financial Services, Inc. (AMEX: LTS) provides retail and institutional securities brokerage, investment banking, investment activities, and asset management services as well as equity research. In May of 2008, Ladenburg Thalmann acquired Punk Ziegel & Company to strengthen its trading, research, and investment banking departments. Ladenburg Thalmann is headquartered in Miami, FL.
View Older Stories View More Recent Stories
-
Sanctuary Wealth Accelerates Growth Strategy with Addition of David Vaughan as Chief Financial Officer
-
Intelligent Bio Solutions (INBS) prices ~570k offering w/warrants at $3.90/share
-
Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering
-
Intelligent Bio Solutions (INBS) Announces Proposed Public Offering
-
Intelligent Bio Solutions Inc. Announces Proposed Public Offering
-
Form X-17A-5 LADENBURG THALMANN & For: Dec 31
-
Apexigen (APGN) Announces Review of Strategic Alternatives and Restructuring
-
Apexigen Announces Review of Strategic Alternatives and Restructuring
-
ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update
-
U.S. inflation accelerates in January, consumer spending surges
-
Aileron Therapeutics (ALRN) Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial, Explores Strategic Alternatives
-
Aileron Therapeutics (ALRN) Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial and Exploration of Strategic Alternatives
-
Aileron Therapeutics Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial and Exploration of Strategic Alternatives
-
Aileron Therapeutics Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial and Exploration of Strategic Alternatives
-
Essential Properties Realty Trust (EPRT) Prices Upsized 7.7M Share Offerings at $24.60/sh
-
Essential Properties Realty Trust, Inc. Announces Pricing of Upsized Public Offering of Common Stock
-
Midatech Pharma PLC Announces Closing of $6.0m Private Placement & Broker Change
-
ADVISOR GROUP CONCLUDES 16TH ANNUAL W FORUM CONFERENCE, ITS LARGEST WOMEN'S EVENT TO DATE
-
Form 13F-NT LADENBURG THALMANN ASSET For: Dec 31
-
Midatech Pharma PLC Announces Private Placement Raising US $6.0 million
-
Sanctuary Wealth Embarks on Next Stage of Growth with Appointment of Adam Malamed As Chief Executive Officer
-
Advisor Group Reports Addition of $84.2 Billion in Total Client Assets and 1,800 Financial Advisors to Its Network in 2022
-
Ladenburg on Palisade Bio Inc. (PALI): 'We are growing more confident in the regulatory path LB1148'
-
PennantPark Floating Rate Capital (PFLT) Prices 4.25M Share Offering at $11.20/sh
-
PennantPark Floating Rate Capital Ltd. Announces Pricing of Public Offering of Common Stock
-
Windtree Therapeutics, Inc. (WINT) Raises $1M from Warrant Exercise
-
Windtree Therapeutics to Raise $1.0 Million From the Exercise of Previously Issued Warrants
-
VICI Properties Inc. Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
VICI Properties Inc. (VICI) Prices Upsized 26.35M Share Offering at $33/sh
-
VICI Properties Inc. Announces Pricing of Upsized Public Offering of Common Stock
-
Vertical Capital Income Fund (VCIF) Announces Transaction and Board Approval of New Investment Advisory Agreement with Carlyle (CG)
-
Vertical Capital Income Fund Announces Transaction and Board Approval of New Investment Advisory Agreement with Carlyle
-
Instant View: U.S. consumer prices fall in December
-
Saratoga Investment Corp. Announces Fiscal Third Quarter 2023 Financial Results
-
Ra Medical Systems Completes Merger with Catheter Precision
-
Palisade Bio Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under Nasdaq Rules
-
Ladenburg Thalmann Reiterates Buy, $119 PT on Kiora Pharmaceuticals (KPRX)
-
Palisade Bio Inc. (PALI) Announces $2.5 Million Registered Direct Offering and Concurrent Private Placement of Common Stock, Warrants
-
Palisade Bio Announces $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under Nasdaq Rules
-
Web3 Ventures Inc. Announces Proposed Sale of the Company’s Securities, Financing, Management and Director Changes and successful conclusion of an Annual and Special Meeting held on December 19th, 2
-
Midatech Pharma PLC Announces Closing of Offering, Revised Terms, AIM & Webinar
-
Harrow Secures Capital to Close Recently Announced Acquisition
-
Harrow Health (HROW) to offer $100 million of senior notes due in 2027
-
Harrow Announces Proposed Offering of $100 Million of Senior Notes Due 2027 and “BB” Rating from Egan-Jones
-
Vallon Pharmaceuticals (VLON) and GRI Bio Enter into Merger Agreement
-
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
-
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
-
Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc
-
Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc
-
Cinedigm to Present at Ladenburg Thalmann Virtual Technology Expo on December 7th

